Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Emerging Company Profile

Santa Ana: Leveraging human multi-omic data for precision immunology

Versant-founded immunology play launches with $168M to create biologics targeted to specific cell types

By Danielle Golovin, Senior Biopharma Analyst
June 13, 2024 11:00 PM UTC

Santa Ana is leveraging learnings from precision oncology and combining them with advances in protein engineering capabilities to create biologics for precision immunology.

Santa Ana Bio Inc. uses genomic, transcriptomic and proteomic approaches to characterize patient subpopulations and identify targets expressed only on disease-causing cell types, leaving healthy cells unaffected...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Santa Ana Bio Inc.